Fundraising Fox

Profusa

NASDAQ: PFSA

San Francisco, US · California corporation · 4 known investors

profusa.com

Profusa develops injectable hydrogel biosensors and AI-driven health platforms that enable real-time measurement of body chemistry from within tissue. The company's Lumee platform addresses oxygen monitoring for vascular surgery patients and continuous glucose monitoring for diabetes and prediabetes patients.

AI & Machine LearningDigital HealthHealthtechMedical Devicesin /profusa@ProfusaInc

Founders & leadership

BF
Bill FawcettCo-founder
BH
Ben HealyCEO
NW
Natalie WisniewskiExecutive Officer, Director
QK
Qianye Karen LiuDirector
BH
Ben HwangExecutive Officer, Director
TG
Thomas GutshallDirector
FC
Fred Craven
DK
Dr. Katharine Rebrin
AT
Aude Taibi
SP
Sean Patterson

Investors · 4

Reported raises · per SEC filings

Form D private placements
$45.1MraisedSep 2018 · 46 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • NG Siu WaiDirector
  • Bill McMillanExecutive Officer
  • Natalie WisniewskiExecutive Officer, Director
  • Joan BraddiDirector
  • Ben HwangExecutive Officer, Director
  • William FristDirector
  • Thomas GutshallDirector
  • Qianye Karen LiuDirector
Offering amount
$50M
Amount sold
$45.1M
First sale
May 2018
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$11.3MraisedJul 2015 · 32 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Natalie WisniewskiExecutive Officer, Director
  • Qianye Karen LiuDirector
  • Ben HwangExecutive Officer, Director
  • Thomas GutshallDirector
Offering amount
$17M
Amount sold
$11.3M
First sale
Jun 2015
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news